Table 2:

Univariate and multivariate analyses of recurrence-free survival (Cox proportional hazard model)

Hazard ratio95% CIP-value
Univariate analysis results
 Age (>67)1.11270.7937–1.56690.5340
 Sex (female)0.79220.5484–1.11660.1861
 Smoking history (no)0.88130.6155–1.23810.4700
 CEA (>5)3.49691.7800–6.99520.0003
 Maximum tumour diameter measured in the lung window (>22.87)1.65501.1746–2.35450.0036
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.65261.7992–4.1892<.0001
 Procedure0.9262
  Wedge resection1
  Lobectomy0.88890.5230–1.7466
  Segmentectomy1.18270.3501–2.6496
  Vessel invasion (yes)5.72482.9146–11.450<0.0001
  Pleural invasion (yes)4.64972.3666–9.3025<0.0001
  Lavage cytology (positive)5.80251.3858–16.4110.0205
1. Multivariate analysis results: tumour size assessment by one-dimensional measurement
 CEA (>5)2.55151.2737–5.19820.0084
 Maximum tumour diameter measured in the lung window (>22.87)0.85420.5684–1.30050.455
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.08301.2547–3.58460.0042
 Vessel invasion (yes)1.98750.9105–4.51470.0850
 Pleural invasion (yes)3.11401.4907–6.53550.0028
 Lavage cytology (positive)1.35360.3057–4.30670.6520
2. Multivariate analysis results: tumour size assessment by two-dimensional measurement
 CEA (>5)2.30431.1495–4.69620.0188
 Area size measured in the mediastinal window (>90.3)1.87001.1673–3.11380.0089
 GGO area size (>167.0)0.55070.2988–0.88340.0111
 Vessel invasion (yes)1.87710.8511–4.29750.1193
 Pleural invasion (yes)2.80571.3542–5.84510.0059
 Lavage cytology (positive)1.39900.3154–4.45510.6186
3. Multivariate analysis results: tumour size assessment by area size ratio (TDR)
 CEA (>5)2.47911.2506–5.00160.0095
 TDR (>0.778)0.32470.1293–0.6056<0.0001
 Vessel invasion (yes)2.26171.0095–4.72570.0267
 Pleural invasion (yes)2.69871.3090–5.59570.0076
 Lavage cytology (positive)1.33010.3045–4.11360.6660
Hazard ratio95% CIP-value
Univariate analysis results
 Age (>67)1.11270.7937–1.56690.5340
 Sex (female)0.79220.5484–1.11660.1861
 Smoking history (no)0.88130.6155–1.23810.4700
 CEA (>5)3.49691.7800–6.99520.0003
 Maximum tumour diameter measured in the lung window (>22.87)1.65501.1746–2.35450.0036
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.65261.7992–4.1892<.0001
 Procedure0.9262
  Wedge resection1
  Lobectomy0.88890.5230–1.7466
  Segmentectomy1.18270.3501–2.6496
  Vessel invasion (yes)5.72482.9146–11.450<0.0001
  Pleural invasion (yes)4.64972.3666–9.3025<0.0001
  Lavage cytology (positive)5.80251.3858–16.4110.0205
1. Multivariate analysis results: tumour size assessment by one-dimensional measurement
 CEA (>5)2.55151.2737–5.19820.0084
 Maximum tumour diameter measured in the lung window (>22.87)0.85420.5684–1.30050.455
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.08301.2547–3.58460.0042
 Vessel invasion (yes)1.98750.9105–4.51470.0850
 Pleural invasion (yes)3.11401.4907–6.53550.0028
 Lavage cytology (positive)1.35360.3057–4.30670.6520
2. Multivariate analysis results: tumour size assessment by two-dimensional measurement
 CEA (>5)2.30431.1495–4.69620.0188
 Area size measured in the mediastinal window (>90.3)1.87001.1673–3.11380.0089
 GGO area size (>167.0)0.55070.2988–0.88340.0111
 Vessel invasion (yes)1.87710.8511–4.29750.1193
 Pleural invasion (yes)2.80571.3542–5.84510.0059
 Lavage cytology (positive)1.39900.3154–4.45510.6186
3. Multivariate analysis results: tumour size assessment by area size ratio (TDR)
 CEA (>5)2.47911.2506–5.00160.0095
 TDR (>0.778)0.32470.1293–0.6056<0.0001
 Vessel invasion (yes)2.26171.0095–4.72570.0267
 Pleural invasion (yes)2.69871.3090–5.59570.0076
 Lavage cytology (positive)1.33010.3045–4.11360.6660

TDR: tumour shadow disappearance rate; GGO: ground glass opacity; CEA: carcinoembryonic antigen; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma.

Table 2:

Univariate and multivariate analyses of recurrence-free survival (Cox proportional hazard model)

Hazard ratio95% CIP-value
Univariate analysis results
 Age (>67)1.11270.7937–1.56690.5340
 Sex (female)0.79220.5484–1.11660.1861
 Smoking history (no)0.88130.6155–1.23810.4700
 CEA (>5)3.49691.7800–6.99520.0003
 Maximum tumour diameter measured in the lung window (>22.87)1.65501.1746–2.35450.0036
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.65261.7992–4.1892<.0001
 Procedure0.9262
  Wedge resection1
  Lobectomy0.88890.5230–1.7466
  Segmentectomy1.18270.3501–2.6496
  Vessel invasion (yes)5.72482.9146–11.450<0.0001
  Pleural invasion (yes)4.64972.3666–9.3025<0.0001
  Lavage cytology (positive)5.80251.3858–16.4110.0205
1. Multivariate analysis results: tumour size assessment by one-dimensional measurement
 CEA (>5)2.55151.2737–5.19820.0084
 Maximum tumour diameter measured in the lung window (>22.87)0.85420.5684–1.30050.455
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.08301.2547–3.58460.0042
 Vessel invasion (yes)1.98750.9105–4.51470.0850
 Pleural invasion (yes)3.11401.4907–6.53550.0028
 Lavage cytology (positive)1.35360.3057–4.30670.6520
2. Multivariate analysis results: tumour size assessment by two-dimensional measurement
 CEA (>5)2.30431.1495–4.69620.0188
 Area size measured in the mediastinal window (>90.3)1.87001.1673–3.11380.0089
 GGO area size (>167.0)0.55070.2988–0.88340.0111
 Vessel invasion (yes)1.87710.8511–4.29750.1193
 Pleural invasion (yes)2.80571.3542–5.84510.0059
 Lavage cytology (positive)1.39900.3154–4.45510.6186
3. Multivariate analysis results: tumour size assessment by area size ratio (TDR)
 CEA (>5)2.47911.2506–5.00160.0095
 TDR (>0.778)0.32470.1293–0.6056<0.0001
 Vessel invasion (yes)2.26171.0095–4.72570.0267
 Pleural invasion (yes)2.69871.3090–5.59570.0076
 Lavage cytology (positive)1.33010.3045–4.11360.6660
Hazard ratio95% CIP-value
Univariate analysis results
 Age (>67)1.11270.7937–1.56690.5340
 Sex (female)0.79220.5484–1.11660.1861
 Smoking history (no)0.88130.6155–1.23810.4700
 CEA (>5)3.49691.7800–6.99520.0003
 Maximum tumour diameter measured in the lung window (>22.87)1.65501.1746–2.35450.0036
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.65261.7992–4.1892<.0001
 Procedure0.9262
  Wedge resection1
  Lobectomy0.88890.5230–1.7466
  Segmentectomy1.18270.3501–2.6496
  Vessel invasion (yes)5.72482.9146–11.450<0.0001
  Pleural invasion (yes)4.64972.3666–9.3025<0.0001
  Lavage cytology (positive)5.80251.3858–16.4110.0205
1. Multivariate analysis results: tumour size assessment by one-dimensional measurement
 CEA (>5)2.55151.2737–5.19820.0084
 Maximum tumour diameter measured in the lung window (>22.87)0.85420.5684–1.30050.455
 Maximum tumour diameter measured in the mediastinal window (>12.52)2.08301.2547–3.58460.0042
 Vessel invasion (yes)1.98750.9105–4.51470.0850
 Pleural invasion (yes)3.11401.4907–6.53550.0028
 Lavage cytology (positive)1.35360.3057–4.30670.6520
2. Multivariate analysis results: tumour size assessment by two-dimensional measurement
 CEA (>5)2.30431.1495–4.69620.0188
 Area size measured in the mediastinal window (>90.3)1.87001.1673–3.11380.0089
 GGO area size (>167.0)0.55070.2988–0.88340.0111
 Vessel invasion (yes)1.87710.8511–4.29750.1193
 Pleural invasion (yes)2.80571.3542–5.84510.0059
 Lavage cytology (positive)1.39900.3154–4.45510.6186
3. Multivariate analysis results: tumour size assessment by area size ratio (TDR)
 CEA (>5)2.47911.2506–5.00160.0095
 TDR (>0.778)0.32470.1293–0.6056<0.0001
 Vessel invasion (yes)2.26171.0095–4.72570.0267
 Pleural invasion (yes)2.69871.3090–5.59570.0076
 Lavage cytology (positive)1.33010.3045–4.11360.6660

TDR: tumour shadow disappearance rate; GGO: ground glass opacity; CEA: carcinoembryonic antigen; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close